Coherus BioSciences, Inc. Profile Avatar - Palmy Investing

Coherus BioSciences, Inc.

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the…

Biotechnology
US, Redwood City [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of CHRS's Analysis
CIK: 1512762 CUSIP: 19249H103 ISIN: US19249H1032 LEI: - UEI: -
Secondary Listings
CHRS has no secondary listings inside our databases.